1 December 2024 false Taxfiler 2024.6 09347024business:PrivateLimitedCompanyLtd2024-12-012025-11-30 093470242024-11-30 093470242024-12-012025-11-30 09347024business:AuditExemptWithAccountantsReport2024-12-012025-11-30 09347024business:FilletedAccounts2024-12-012025-11-30 093470242025-11-30 09347024business:Director12024-12-012025-11-30 09347024business:RegisteredOffice2024-12-012025-11-30 093470242024-11-30 09347024core:WithinOneYear2025-11-30 09347024core:WithinOneYear2024-11-30 09347024core:AfterOneYear2025-11-30 09347024core:AfterOneYear2024-11-30 09347024core:ShareCapitalcore:PreviouslyStatedAmount2025-11-30 09347024core:ShareCapitalcore:PreviouslyStatedAmount2024-11-30 09347024core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-11-30 09347024core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-11-30 09347024core:PreviouslyStatedAmount2025-11-30 09347024core:PreviouslyStatedAmount2024-11-30 09347024business:SmallEntities2024-12-012025-11-30 09347024countries:EnglandWales2024-12-012025-11-30 09347024core:ComputerEquipment2024-11-30 09347024core:ComputerEquipment2025-11-30 093470242023-12-012024-11-30 iso4217:GBP xbrli:pure
Company Registration No. 09347024 (England and Wales)
APEX MEDICAL CONSULTING LTD Unaudited accounts for the year ended 30 November 2025
APEX MEDICAL CONSULTING LTD Unaudited accounts Contents
Page
- 2 -
APEX MEDICAL CONSULTING LTD Company Information for the year ended 30 November 2025
Director
Dr Omolaja Sharafadeen Kassim
Company Number
09347024 (England and Wales)
Registered Office
77 LONDON LANE BROMLEY KENT BR1 4HF
Accountants
LIBRA ASSOCIATES (UK) LTD 133 CREEK ROAD GREENWICH LONDON SE8 3BU
- 3 -
APEX MEDICAL CONSULTING LTD Statement of financial position as at 30 November 2025
2025 
2024 
Notes
£ 
£ 
Current assets
Debtors
3,980 
5,760 
Cash at bank and in hand
41,736 
31,484 
45,716 
37,244 
Creditors: amounts falling due within one year
8,690 
15,050 
Net current assets
54,406 
52,294 
Total assets less current liabilities
54,406 
52,294 
Creditors: amounts falling due after more than one year
(25,873)
(31,078)
Net assets
28,533 
21,216 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
28,532 
21,215 
Shareholders' funds
28,533 
21,216 
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 27 August 2026 and were signed on its behalf by
Dr Omolaja Sharafadeen Kassim Director Company Registration No. 09347024
- 4 -
APEX MEDICAL CONSULTING LTD Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
APEX MEDICAL CONSULTING LTD is a private company, limited by shares, registered in England and Wales, registration number 09347024. The registered office is 77 LONDON LANE, BROMLEY, KENT, BR1 4HF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 December 2024
2,586 
At 30 November 2025
2,586 
Depreciation
At 1 December 2024
2,586 
At 30 November 2025
2,586 
Net book value
At 30 November 2025
- 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Trade debtors
3,980 
5,760 
- 5 -
APEX MEDICAL CONSULTING LTD Notes to the Accounts for the year ended 30 November 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Loans from directors
(10,690)
(17,050)
Accruals
2,000 
2,000 
(8,690)
(15,050)
7
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Bank loans
25,873 
31,078 
8
Transactions with related parties
The company was under the control of Dr Omolaja Sharafadeen Kassim who owns 100% of the issued share capital. Dr Omolaja Sharafadeen Kassim received a dividend of £40,000
9
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 6 -